Effectiveness of Atorvastatin for Reducing Low-Density Lipoprotein Cholesterol to National Cholesterol Education Program Treatment Goals
- 1 August 1997
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (3) , 347-348
- https://doi.org/10.1016/s0002-9149(97)00360-3
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Inadequate treatment with HMG-CoA reductase inhibitors by health care providersThe American Journal of Medicine, 1996
- Task force 4. Efficacy of risk factor managementJournal of the American College of Cardiology, 1996
- Efficacy and Safety of a New HMG-CoA Reductase Inhibitor, Atorvastatin, in Patients With HypertriglyceridemiaJAMA, 1996
- Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase InhibitorArteriosclerosis, Thrombosis, and Vascular Biology, 1995